Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe

  Malignant Lymphoma

  Free Subscription

Articles published in Int J Cancer

Retrieve available abstracts of 46 articles:
HTML format

Single Articles

    April 2020
  1. LI M, Shen Y, Chen Y, Gao H, et al
    Characterization of hepatitis B virus infection and viral DNA integration in non-Hodgkin lymphoma.
    Int J Cancer. 2020 Apr 29. doi: 10.1002/ijc.33027.
    PubMed     Abstract available

    March 2020
  2. NAUDIN S, Solans Margalef M, Saberi Hosnijeh F, Nieters A, et al
    Healthy lifestyle and the risk of lymphoma in the EPIC study.
    Int J Cancer. 2020 Mar 16. doi: 10.1002/ijc.32977.
    PubMed     Abstract available

  3. TAJ T, Poulsen AH, Ketzel M, Geels C, et al
    Long-Term Exposure to Air Pollution and Risk of Non-Hodgkin lymphoma in Denmark: A Population-based Case-Control Study.
    Int J Cancer. 2020 Mar 16. doi: 10.1002/ijc.32978.
    PubMed     Abstract available

  4. DIETZ A, Dalda N, Zielke S, Dittmann J, et al
    Proteasome inhibitors and Smac mimetics cooperate to induce cell death in Diffuse Large B-cell Lymphoma by stabilizing NOXA and triggering mitochondrial apoptosis.
    Int J Cancer. 2020 Mar 13. doi: 10.1002/ijc.32976.
    PubMed     Abstract available

    October 2019
  5. LIU Z, Jarrett RF, Hjalgrim H, Proietti C, et al
    Evaluation of the antibody response to the EBV proteome in EBV-associated classic Hodgkin lymphoma.
    Int J Cancer. 2019 Oct 16. doi: 10.1002/ijc.32741.
    PubMed     Abstract available

    September 2019
  6. CHONG Y, Liu Y, Lu S, Cai B, et al
    Critical individual roles of the BCR and FGFR1 kinase domains in BCR-FGFR1-driven stem cell leukemia/lymphoma syndrome.
    Int J Cancer. 2019 Sep 16. doi: 10.1002/ijc.32665.
    PubMed     Abstract available

  7. PURDUE MP, Lan Q, Langseth H, Grimsrud TK, et al
    Pre-diagnostic serum sCD27 and sCD30 in serial samples and risks of non-Hodgkin lymphoma subtypes.
    Int J Cancer. 2019 Sep 15. doi: 10.1002/ijc.32684.
    PubMed     Abstract available

    May 2019
  8. PARODI S, Seniori Costantini A, Crosignani P, Fontana A, et al
    Childhood infectious diseases and risk of non-Hodgkin's lymphoma according to the WHO classification: a reanalysis of the Italian multicentre case-control study.
    Int J Cancer. 2019 May 11. doi: 10.1002/ijc.32393.
    PubMed     Abstract available

  9. PEPRAH S, Ogwang MD, Kerchan P, Reynolds SJ, et al
    Risk factors for Burkitt lymphoma in East African children and minors: a case-control study in malaria-endemic regions in Uganda, Tanzania, and Kenya.
    Int J Cancer. 2019 May 4. doi: 10.1002/ijc.32390.
    PubMed     Abstract available

  10. CHATTOPADHYAY S, Zheng G, Sud A, Sundquist K, et al
    Second primary cancers in non-Hodgkin lymphoma: family history and survival.
    Int J Cancer. 2019 May 4. doi: 10.1002/ijc.32391.
    PubMed     Abstract available

  11. MAGUIRE A, Chen X, Wisner L, Malasi S, et al
    Enhanced DNA repair and genomic stability identify a novel HIV related Diffuse Large B-cell Lymphoma signature.
    Int J Cancer. 2019 May 1. doi: 10.1002/ijc.32381.
    PubMed     Abstract available

    April 2019
  12. BASSIG BA, Shu XO, Sjodin A, Koh WP, et al
    Pre-diagnostic blood levels of organochlorines and risk of non-Hodgkin lymphoma in three prospective cohorts in China and Singapore.
    Int J Cancer. 2019 Apr 19. doi: 10.1002/ijc.32350.
    PubMed     Abstract available

  13. PARK LC, Song YJ, Kim DJ, Kim MJ, et al
    The effects of erythropoiesis-stimulating agents on the management of chemotherapy-induced anemia and tumor growth in diffuse large B-cell lymphoma patients.
    Int J Cancer. 2019 Apr 11. doi: 10.1002/ijc.32328.
    PubMed     Abstract available

    January 2019
  14. WEIBULL CE, Bjorkholm M, Glimelius I, Lambert PC, et al
    Temporal trends in treatment-related incidence of diseases of the circulatory system among Hodgkin lymphoma patients.
    Int J Cancer. 2019 Jan 21. doi: 10.1002/ijc.32142.
    PubMed     Abstract available

  15. WANG X, Zhang T, Song Z, Li L, et al
    Tumor CD73/A2aR adenosine immunosuppressive axis and tumor-infiltrating lymphocytes in diffuse large B-cell lymphoma: Correlations with clinicopathological characteristics and clinical outcome.
    Int J Cancer. 2019 Jan 21. doi: 10.1002/ijc.32144.
    PubMed     Abstract available

    December 2018
  16. SOLANS M, Benavente Y, Saez M, Agudo A, et al
    Adherence to the Mediterranean diet and lymphoma risk in the European Prospective Investigation into Cancer and Nutrition.
    Int J Cancer. 2018 Dec 26. doi: 10.1002/ijc.32091.
    PubMed     Abstract available

    November 2018
  17. JOKO-FRU WY, Parkin DM, Borok M, Chokunonga E, et al
    Survival from childhood cancers in Eastern Africa: A population-based registry study.
    Int J Cancer. 2018;143:2409-2415.
    PubMed     Abstract available

    October 2018
  18. SUBRAMANIAN K, Dierckx T, Khouri R, Menezes SM, et al
    Decreased RORC expression and downstream signaling in HTLV-1-associated Adult T-cell Lymphoma/Leukemia uncovers an antiproliferative IL17 link: a potential target for immunotherapy?
    Int J Cancer. 2018 Oct 10. doi: 10.1002/ijc.31922.
    PubMed     Abstract available

    September 2018
  19. DAVIS JM, Garb Y
    A strong spatial association between e-waste burn sites and childhood lymphoma in the West Bank, Palestine.
    Int J Cancer. 2018 Sep 27. doi: 10.1002/ijc.31902.
    PubMed     Abstract available

  20. CHATTOPADHYAY S, Sud A, Zheng G, Yu H, et al
    Second primary cancers in non-Hodgkin lymphoma: Bidirectional analyses suggesting role for immune dysfunction.
    Int J Cancer. 2018 Sep 21. doi: 10.1002/ijc.31801.
    PubMed     Abstract available

  21. PURDUE MP, Lan Q, Hoffman-Bolton J, Hildesheim A, et al
    Circulating sCD27 and sCD30 in pre-diagnostic samples collected fifteen years apart and future non-Hodgkin lymphoma risk.
    Int J Cancer. 2018 Sep 19. doi: 10.1002/ijc.31879.
    PubMed     Abstract available

    August 2018
  22. YE X, Zhang G, Righolt C, Johnston JB, et al
    Associations between statin use and risk of non-Hodgkin lymphomas by subtype.
    Int J Cancer. 2018;143:971-979.
    PubMed     Abstract available

    May 2018
  23. CHIU YH, Bertrand KA, Zhang S, Laden F, et al
    A prospective analysis of circulating saturated and monounsaturated fatty acids and risk of non-Hodgkin lymphoma.
    Int J Cancer. 2018 May 14. doi: 10.1002/ijc.31602.
    PubMed     Abstract available

  24. GAO R, Liang JH, Wang L, Zhu HY, et al
    Low Serum Cholesterol Levels Predict Inferior Prognosis and Improve NCCN-IPI Scoring in Diffuse Large B Cell Lymphoma.
    Int J Cancer. 2018 May 9. doi: 10.1002/ijc.31590.
    PubMed     Abstract available

    April 2018
  25. BANDAPALLI OR, Paramasivam N, Giangiobbe S, Kumar A, et al
    Whole genome sequencing reveals DICER1 as a candidate predisposing gene in familial Hodgkin lymphoma.
    Int J Cancer. 2018 Apr 30. doi: 10.1002/ijc.31576.

  26. VERMEULEN R, Saberi Hosnijeh F, Bodinier B, Portengen L, et al
    Pre-diagnostic blood immune markers, incidence and progression of B-cell lymphoma and multiple myeloma; univariate and functionally-informed multivariate analyses.
    Int J Cancer. 2018 Apr 18. doi: 10.1002/ijc.31536.
    PubMed     Abstract available

  27. MPUNGA T, Znaor A, Uwizeye FR, Uwase A, et al
    A case-control study of HIV infection and cancer in the era of antiretroviral therapy in Rwanda.
    Int J Cancer. 2018 Apr 16. doi: 10.1002/ijc.31537.
    PubMed     Abstract available

  28. RAASCHOU-NIELSEN O, Hvidtfeldt U, Roswall N, Hertel O, et al
    Ambient benzene at the residence and risk for subtypes of childhood leukaemia, lymphoma and CNS tumour.
    Int J Cancer. 2018 Apr 6. doi: 10.1002/ijc.31421.
    PubMed     Abstract available

    March 2018
  29. CALIP GS, Patel PR, Adimadhyam S, Xing S, et al
    Tumor necrosis factor-alpha inhibitors and risk of non-Hodgkin lymphoma in a cohort of adults with rheumatologic conditions.
    Int J Cancer. 2018 Mar 30. doi: 10.1002/ijc.31407.
    PubMed     Abstract available

  30. BASSIG BA, Willhauck-Fleckenstein M, Shu XO, Koh WP, et al
    Serologic markers of viral infection and risk of non-Hodgkin lymphoma: A pooled study of three prospective cohorts in China and Singapore.
    Int J Cancer. 2018 Mar 25. doi: 10.1002/ijc.31385.
    PubMed     Abstract available

    November 2017
  31. COWELL JK, Qin H, Hu T, Wu Q, et al
    Mutation in the FGFR1 tyrosine kinase domain or inactivation of PTEN is associated with acquired resistance to FGFR inhibitors in FGFR1-driven leukemia/lymphomas.
    Int J Cancer. 2017;141:1822-1829.
    PubMed     Abstract available

    October 2017
  32. JAYASEKARA H, Juneja S, Hodge AM, Room R, et al
    Lifetime alcohol intake and risk of non-Hodgkin lymphoma: Findings from the Melbourne Collaborative Cohort Study.
    Int J Cancer. 2017 Oct 21. doi: 10.1002/ijc.31123.
    PubMed     Abstract available

  33. MAWSON AR, Majumdar S
    Malaria, Epstein-Barr virus, vitamin A, and Burkitt's lymphoma: Response to Joob and Wiwanitkit.
    Int J Cancer. 2017 Oct 21. doi: 10.1002/ijc.31122.

  34. JOOB B, Wiwanitkit V
    Malaria, Epstein-Barr virus, vitamin A and Burkitt's lymphoma.
    Int J Cancer. 2017 Oct 21. doi: 10.1002/ijc.31118.

  35. HOSRY J, Miranda RN, Samaniego F, Economides MP, et al
    Clinicopathologic Characteristics and Outcomes of Transformed Diffuse Large B-Cell Lymphoma in Hepatitis C Virus-Infected Patients.
    Int J Cancer. 2017 Oct 19. doi: 10.1002/ijc.31110.
    PubMed     Abstract available

  36. BIASOLI I, Castro N, Delamain M, Silveira T, et al
    Lower socioeconomic status is independently associated with shorter survival in Hodgkin Lymphoma patients - an analysis from the Brazilian Hodgkin Lymphoma Registry.
    Int J Cancer. 2017 Oct 11. doi: 10.1002/ijc.31096.
    PubMed     Abstract available

    September 2017
  37. LI J, Wang X, Xie Y, Ying Z, et al
    The mTOR kinase inhibitor everolimus synergistically enhances the anti-tumor effect of the Bruton's tyrosine kinase (BTK) inhibitor PLS-123 on Mantle cell lymphoma.
    Int J Cancer. 2017 Sep 14. doi: 10.1002/ijc.31044.
    PubMed     Abstract available

    August 2017
  38. CHASIMPHA SJD, Parkin DM, Masamba L, Dzamalala CP, et al
    Three-year cancer incidence in Blantyre, Malawi (2008-2010).
    Int J Cancer. 2017;141:694-700.
    PubMed     Abstract available

  39. JOCHEMS C, Hodge JW, Fantini M, Tsang KY, et al
    ADCC employing an NK cell line (haNK) expressing the high affinity CD16 allele with avelumab, an anti-PD-L1 antibody.
    Int J Cancer. 2017;141:583-593.
    PubMed     Abstract available

    July 2017
  40. MAWSON AR, Majumdar S
    Malaria, Epstein-Barr virus infection, and the Pathogenesis of Burkitt's Lymphoma.
    Int J Cancer. 2017 Jul 13. doi: 10.1002/ijc.30885.
    PubMed     Abstract available

    June 2017
  41. ZENZ T, Kreuz M, Fuge M, Klapper W, et al
    TP53 mutation and survival in aggressive B cell lymphoma.
    Int J Cancer. 2017 Jun 14. doi: 10.1002/ijc.30838.
    PubMed     Abstract available

    May 2017
  42. JANKET SJ, Ackerson LK, Meurman JH
    Potential reverse causation?
    Int J Cancer. 2017;140:2168.

    April 2017
  43. HAVERKOS BM, Huang Y, Gru A, Pancholi P, et al
    Frequency and clinical correlates of elevated plasma Epstein-Barr virus DNA at diagnosis in peripheral T-cell lymphomas.
    Int J Cancer. 2017;140:1899-1906.
    PubMed     Abstract available

    March 2017
  44. SHETZER Y, Napchan Y, Kaufman T, Molchadsky A, et al
    Immune deficiency augments the prevalence of p53 loss of heterozygosity in spontaneous tumors but not bi-directional loss of heterozygosity in bone marrow progenitors.
    Int J Cancer. 2017;140:1364-1369.
    PubMed     Abstract available

    November 2016
  45. ROTTENBERG Y, Levine H, Keinan-Boker L, Derazne E, et al
    Risk of nasopharyngeal carcinoma penetrates across immigrant generations: A migrant cohort study of 2.3 million Jewish Israeli adolescents.
    Int J Cancer. 2016 Nov 16. doi: 10.1002/ijc.30525.
    PubMed     Abstract available

    August 2016
  46. HALABI MA, Jaccard A, Moulinas R, Bahri R, et al
    Clonal deleted latent membrane protein 1 variants of Epstein-Barr virus are predominant in European extranodal NK/T lymphomas and disappear during successful treatment.
    Int J Cancer. 2016;139:793-802.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.